Literature DB >> 35373592

Eight Tales of Cervical Necrotizing Fasciitis and Free Tissue Transfer.

Nicholas A Rapoport1, David S Lee1, Jake J Lee1, Sidharth V Puram1, Ryan S Jackson1, Patrik Pipkorn1.   

Abstract

OBJECTIVES: Aggressive surgical debridement is required in cervical necrotizing fasciitis, and in severe defects, subsequent free tissue transfer might be necessary. However, there is concern that the inflammatory environment of the infection site may threaten free flap viability, particularly with concerns for thrombosis of feeding vessels and compromised tissue integration. Cases in the head and neck area are rare, so there are limited data regarding outcomes of free tissue transfer in these patients.
METHODS: A retrospective chart review assessed patients with cervical necrotizing fasciitis treated at an academic tertiary hospital between 2015 and 2021. Twenty-five patients were identified, and eight required free tissue transfer after adequate surgical debridement. Treatment, hospital course, and demographic data were collected on these eight patients.
RESULTS: All flaps had full survival at follow up (median follow up 3 months, range 1-39 months) without concerns for vascular compromise.
CONCLUSION: These data suggest that in patients with large soft tissue defects due to cervical necrotizing fasciitis, free tissue transfer may be a safe treatment modality.

Entities:  

Keywords:  deep neck infection; free flap reconstruction; free tissue transfer; head and neck surgery; otolaryngology

Year:  2022        PMID: 35373592      PMCID: PMC9526756          DOI: 10.1177/00034894221088179

Source DB:  PubMed          Journal:  Ann Otol Rhinol Laryngol        ISSN: 0003-4894            Impact factor:   1.973


  16 in total

Review 1.  Special issues in plastic and reconstructive surgery.

Authors:  Gerard J Fulda; Sami U Khan; David D Zabel
Journal:  Crit Care Clin       Date:  2003-01       Impact factor: 3.598

2.  Diagnosis and management of necrotizing fasciitis of the head and neck.

Authors:  Haldun Oguz; M Sinan Yilmaz
Journal:  Curr Infect Dis Rep       Date:  2012-04       Impact factor: 3.725

Review 3.  Necrotizing fasciitis: review of the literature and case report.

Authors:  Adam Weiss; Peter Nelson; Reza Movahed; Earl Clarkson; Harry Dym
Journal:  J Oral Maxillofac Surg       Date:  2011-03-01       Impact factor: 1.895

Review 4.  Early diagnosis of necrotizing fasciitis.

Authors:  T Goh; L G Goh; C H Ang; C H Wong
Journal:  Br J Surg       Date:  2013-11-29       Impact factor: 6.939

5.  Trends in 393 necrotizing acute soft tissue infection patients 2000-2008.

Authors:  Nicole P Bernal; Barbara A Latenser; Janelle M Born; Junlin Liao
Journal:  Burns       Date:  2011-10-24       Impact factor: 2.744

6.  Free tissue transfer for necrotizing fasciitis reconstruction: A case series.

Authors:  Justin Peter Gawaziuk; Tianyi Liu; Leif Sigurdson; Edward Buchel; Thomas Edward Jo Hayakawa; Sarah Shiga; Sarvesh Logsetty
Journal:  Burns       Date:  2017-05-20       Impact factor: 2.744

7.  Successful Salvage of Late Anastomotic Thrombosis after Free Tissue Transfer.

Authors:  Peter W Henderson; John G Fernandez; Yeliz Cemal; Babak J Mehrara; Andrea L Pusic; Colleen M McCarthy; Evan Matros; Peter G Cordeiro; Joseph J Disa
Journal:  J Reconstr Microsurg       Date:  2016-02-12       Impact factor: 2.873

Review 8.  Cervical necrotizing fasciitis with descending mediastinitis: literature review and case report.

Authors:  Thomas Sarna; Trina Sengupta; Michael Miloro; Antonia Kolokythas
Journal:  J Oral Maxillofac Surg       Date:  2011-08-06       Impact factor: 1.895

9.  Necrotizing fasciitis of the head and neck.

Authors:  Henning Wolf; Maria Rusan; Karin Lambertsen; Therese Ovesen
Journal:  Head Neck       Date:  2010-12       Impact factor: 3.147

10.  Necrotizing fasciitis: clinical presentation, microbiology, and determinants of mortality.

Authors:  Chin-Ho Wong; Haw-Chong Chang; Shanker Pasupathy; Lay-Wai Khin; Jee-Lim Tan; Cheng-Ooi Low
Journal:  J Bone Joint Surg Am       Date:  2003-08       Impact factor: 5.284

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.